No non-convertible securities with payments due in Q3 FY27

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹29.00

prior close

₹29.80

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+1.3% vs market

Non Banking Financial Company (NBFC) peers, median of 220sector-0.6%+0.6% vs sector

On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 0.6 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-1.3+1.3-0.6+0.6

Next day

-0.1-1.3+1.2-0.6+0.5

+6.8+0.0+6.8-0.6+7.4

+0.0-0.2+0.3-1.1+1.1

+3.4-3.0+6.4-2.5+5.9

+5.2-2.7+7.9-1.8+7.0

+8.8-1.7+10.5-0.5+9.3

15d

+20.7-8.9+29.6-5.5+26.2

—————

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 220Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Prism Medico and Pharmacy has informed BSE and MSE that under SEBI LODR Regulation 57(4), the company has not issued any non-convertible securities requiring interest, dividend or principal payments during the quarter from 1 October 2026 to 31 December 2026. This is a routine compliance filing confirming nil obligations for the period.

Likely market impact

Routine compliance filing with no material impact on shareholders or stock price.